Pfizer CEO Albert Bourla speaks shakes hands with U.S. President Donald Trump in a White House event on Tuesday.
Getty Images
President Trump and Pfizer announced a deal to cut drug pricing yesterday. And it looks like the pharmaceutical giant got the better end of it. Signed at a showy news conference on Tuesday, the agreement gives CEO Albert Bourla and his company a reprieve from threatened tariffs and something of a truce from an Administration that he had been battling. It was a win so…
Continue Reading
News Source: www.forbes.com
Leave a Reply